Brief: Sensorion Announces Positive Data From Gene Therapy Programme

Sensorion SA

09/06/2020 06:51

June 9 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES POSITIVE PRELIMINARY PRECLINICAL DATA
FROM
ITS OTOFERLIN GENE THERAPY PROGRAM
    * IN VIVO EXPERIMENTS CONDUCTED SAFELY IN NON-HUMAN PRIMATES
SHOW
PROMISING PRELIMINARY DATA ON INNER EAR TISSUE TROPISM AND
ACHIEVEMENT OF A HIGH TRANSDUCTION RATE EFFICIENCY
    * FRENCH GOVERNMENT AWARDED UP TO EUR 9.7 MLN TO "AUDINNOVE"
CONSORTIUM TO SUPPORT DEVELOPMENT OF OTOF PROGRAM INTO HUMAN
CLINICAL TRIALS

Source text for Eikon:  ID:nBw2QbRqta 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))